Cross-Trial Analysis Of Fixed-Duration Ibrutinib (I) Plus Venetoclax (V) Vs Fludarabine (F), Cyclophosphamide (C), And Rituximab (R) As First-Line Treatment For Chronic Lymphocytic Leukemia (Cll)
Ibrutinib;Venetoclax;Cyclophosphamide;Fludarabine;Rituximab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Cross-Trial Analysis Of Fixed-Duration Ibrutinib (I) Plus Venetoclax (V) Vs Fludarabine (F), Cyclophosphamide (C), And Rituximab (R) As First-Line Treatment For Chronic Lymphocytic Leukemia (Cll) ### Output: Ibrutinib;Venetoclax;Cyclophosphamide;Fludarabine;Rituximab